MPA News and Research

RSS

SILVER Study provides insight into the challenges presented by COVID-19 to older New Yorkers

ICAP at Columbia University Mailman School of Public Health has released results from Round Two of the SILVER Study, providing insight into the challenges presented by COVID-19 to older adults living at home in New York City.

20 Dec 2022

To attract in-home caregivers, California offers paid training — and self-care

One November afternoon, Chris Espedal asked a group of caregivers — all of whom work with people who have cognitive impairments, behavioral health issues, or complex physical needs — to describe what happens when their work becomes too much to bear.

9 Dec 2022

Researchers fabricate a non-porous biodegradable vascular graft

Researchers developed a novel small-diameter biodegradable vascular graft that aids the formation of elastin-containing structures in the intima-media, which is important for the normal functioning of the artery.

26 Oct 2022

First real-world study shows the effectiveness of mRNA COVID-19 vaccines during pregnancy

The first large, real-world study of the effectiveness of mRNA COVID-19 vaccines during pregnancy found these vaccines, especially two initial doses followed by a booster, are effective in protecting against serious disease in expectant mothers whether the shots are administered before or during pregnancy.

27 Sep 2022

Hypertension heightens the risk of hospitalization related to SARS-CoV-2 Omicron infection

Hypertension more than doubles the risk of hospitalization related to Omicron infection, even in people who are fully vaccinated and boosted, according to a new study led by investigators in the Smidt Heart Institute at Cedars-Sinai.

29 Jul 2022

New Nexera™ XS inert UHPLC System Eliminates Challenges of High-Concentration Mobile Phases to Achieve High Sensitivity and Reliability

Shimadzu Scientific Instruments introduces the Nexera™ XS inert Ultra High Performance Liquid Chromatograph (UHPLC), which eliminates the risk of adsorption or corrosion by high-concentration mobile phases.

From Shimadzu Scientific Instruments 28 Jul 2022

nTIDE monthly report highlights the significant increase in employment for people with disabilities

Employment increased slightly from May to June for people with disabilities, reaching an all-time high.

8 Jul 2022

Social media can be a powerful tool for communication during disasters

Everyone knows that while disinformation is a problem, social media is a powerful tool for communicating fast in an emergency.

27 May 2022

Health dashboards are here to stay and can efficiently guide public health action in the future

An editorial authored by Regenstrief Institute and Indiana University Richard M. Fairbanks School of Public Health research scientists and published in the American Journal of Public Health calls for investing in people, processes and technology so health dashboards, so useful and popular during the COVID-19 pandemic, can efficiently and effectively guide public health action in the future, tracking concerns such as cancer, HIV, traffic injuries or the next emerging public health threat.

26 Apr 2022

Study highlights the benefits of COVID-19 care at long-term acute care hospitals

Patients with severe COVID-19 and related complications can benefit from receiving postacute care at long-term acute care hospitals (LTACHs), a new report suggests.

30 Mar 2022

Evaluating serological responses to repeated COVID-19 vaccination in kidney transplant recipients

Researchers analyzed whether repeated vaccinations against COVID-19 increase serological response in non-responding kidney transplant recipients.

29 Mar 2022

NYU Grossman School of Medicine’s graduating students matched into top residency programs

On Friday, March 18, after a two-year hiatus, graduating students at NYU Grossman School of Medicine gathered in person for Match Day 2022 to learn where they would be for the next phase in their medical training.

18 Mar 2022

Research highlights the impact of HIE-based event notifications on care coordination

Provider alerts triggered by health information exchange (HIE) data are becoming much more common, and soon the U.S. Centers for Medicare and Medicaid will require them.

4 Mar 2022

CDC study first to show waning immunity after third dose of mRNA COVID-19 vaccine

A nationwide study from the U.S. Centers for Disease Control and Prevention is the first to show that immunity against severe COVID-19 disease begins to wane 4 months after receipt of the third dose of an mRNA vaccine (Pfizer or Moderna).

12 Feb 2022

Higher social determinants of health burden linked to increase in obesity

Cumulative social disadvantage, as denoted by higher social determinants of health (SDOH) burden, is associated with a higher likelihood of obesity independent of clinical and demographic factors, according to a new study in Obesity, The Obesity Society's (TOS) flagship journal.

27 Jan 2022

Third dose of mRNA vaccine found to be effective in protecting against Omicron-related ED visits

A nationwide study from the Centers for Disease Control and Prevention (CDC) has found that mRNA booster shots (either Pfizer or Moderna) are 82 percent effective in protecting against COVID-19 Omicron variant-associated emergency department (ED) visits and 90 percent effective in protecting against COVID-19 Omicron variant-related hospitalizations.

24 Jan 2022

Withdrawing steroid treatment found to boost SARS-CoV-2 vaccine-induced immunity in kidney transplant recipients

In a new study, a team of researchers investigated the impact of the fourth dose of a vaccine against COVID-19 in kidney transplant recipients, who had not mounted a humoral immune response to three doses of vaccine.

11 Jan 2022

Transplant recipients benefit from a COVID-19 vaccine booster

A new preprint research paper posted to the medRxiv* server describes the reduction in humoral immunity in SOTR following vaccination, as well as the improvement with an additional dose of the vaccine.

4 Jan 2022

Study: mRNA vaccines associated with more immunity than prior COVID-19 infection

A nationwide study from the Centers for Disease Control and Prevention shows that mRNA COVID-19 vaccines are associated with significantly more immunity than a prior COVID-19 infection.

29 Oct 2021

Study sheds light on neurologic symptoms caused by SARS-CoV-2 infection

Researchers in Australia and Finland have provided important insights into how infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – might affect nervous system circuitries and cause neurologic symptoms.

6 Sep 2021